Horrobin, D.F.; Vaddadi, K.S.; Glen, A.I.M.; Cooper, S.; Fahey, J.; Rybakowski, J.; Shay, J.
Arachidonic and docosahexaenoic acid levels in blood in schizophrenics who do and do not flush to oral niacin (Abstract)
Biol Psychiatry (World Congress of Biological Psychiatry, Nice, June 1997) 1997; 42(1 Supp1): 232S.


200 mg niacin given orally causes marked facial flushing because of release of arachidonic acid and its conversion to prostaglandin D2. Normal individuals, bipolar patients and depressed patients all flush. 20-40% of unselected schizophrenic patients do not flush in this test and a preponderance of those who do not flush exhibit the negative syndrome. 69 schizophrenics from Scotland, Ireland, Poland and Australia were selected on clinical grounds as having a predominantly negative syndrome. 33 flushed in response to oral niacin and 36 did not. There were no important differences in drug treatment between the groups, indicating that flushing status was not related to drugs. However, red cell AA and DHA levels were significantly decreased and plasma AA and DHA levels were increased in the non-flushers as compared to the flushers. Both groups showed significantly decreased red cell AA and DHA as compared to control. This study confirms again that schizophrenics have reduced red cell membrane AA and DHA levels and demonstrates that the abnormality is more severe in schizophrenics who do not flush in response to oral niacin.

All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact